Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

7 companies in the race to make an artificial pancreas

March 31, 2017 By Fink Densford

Bigfoot Biomedical: The artificial pancreas company with DIY roots

Bigfoot Biomedical stepped out of the shadows in the summer of 2015, looking to develop their own artificial pancreas system with the help of Bryan Mazlish, a former player in quantitative finance who used his knowledge of algorithms to develop a homebrew “bionic pancreas” for his wife and son.

Both Mazlish’s son and wife used his hacked artificial pancreas devices for over a year, according to interviews with the family. A Wired article in 2014 covering home diabetes device hackers surreptitiously referred to Mazlish as “bigfoot” to hide his identity. The name stuck.

Since then, Bigfoot has rocketed forward, winning support from the Juvenile Diabetes Research Foundation, which in January made an unspecified equity investment through its T1D Fund into the company and the Smartloop automated insulin delivery system it’s developing.

Bigfoot bills the Smartloop system as “the world’s 1st Internet-of-Things medical device system delivered as a monthly service,” based on a “cloud-connected ecosystem” designed to link wearable insulin delivery and glucose monitoring devices controlled via smartphone.

Bigfoot in mid-2015 bought the assets of shuttered insulin pump maker Asante and moved into its Silicon Valley headquarters, saying it planned to integrate Asante’s FDA-cleared Snap insulin pump into its own system. A year later, Bigfoot launched a clinical trial of the Smartloop platform. The company has inked deals with “leading glucose monitoring companies,” including Dexcom and now employs some 40 workers.

Last October, Milpitas, Calif.–based Bigfoot raised a $35.5 million Series A round led by Quadrant Capital Advisors that included backing from Cormorant Asset Management, Senvest Capital and Visionnaire Ventures. Bigfoot said at the time that it plans to use the proceeds to fund the final development of the Smartloop system.

The company initiated its 1st clinical trial last January and has since completed the trial, which included both adult and pediatric participants, and is hopeful that it will begin a pivotal trial of its devices later this year at multiple clinical sites in the US.

Next>>

Pages: 1 2 3 4 5 6 7 8 9

Comments

  1. Gayle Kirma says

    April 3, 2017 at 7:49 pm

    I’m patiently waiting for this to hit the marke; T1 for 58 years!

    Thank you!

    • Chris Newmarker says

      April 4, 2017 at 4:30 pm

      Thanks for the comment, Gayle. Hope you don’t have to wait much longer!

  2. James Dunlop says

    April 5, 2017 at 5:47 am

    but what about the advancements in this? worth looking at, it is being investigated by the same people that are investing in this product. hope for us T1 diabetics is coming, one way or another. there is hope.

    http://thejdca.org/practical-cure-project-update-bcg

  3. Erika Payne says

    April 5, 2017 at 12:43 pm

    Hats off to you, Gayle.

    Waiting impatiently.

    Mum of a 10-year-old T1

  4. Debbie says

    April 5, 2017 at 8:01 pm

    How do i get to be in the trial?

  5. Ronnie McBride says

    April 5, 2017 at 11:58 pm

    This will be great. I am 67 years old and am fighting the battle of diabetes. I would love to trial test something like this. I worked in the Medical field for 39 years and was always studying how to beat this terrible disease.

    Ronnie McBride

  6. James Culp says

    April 6, 2017 at 12:12 am

    I wish all success. I hope for biological approach to protect islet insulin producing cells for implant or infusion of cells to restore natural function of glucose metabolism. May God help us.

  7. Pat McAlister says

    June 3, 2017 at 4:59 pm

    T1D for 70 years. Why not a cure instead of costing us more and more to live. We are the support of these drug and device companies. Thank you for this article. I do a diabetic newsletter for a T1D optimist club. Our next speaker is building his own device.

    • Chris Newmarker says

      June 5, 2017 at 6:20 pm

      Thanks for the insights, Pat. I think it really says something about the motivation of the diabetes community that there’s so much do-it-yourself activity going on with devices, including when it comes to an artificial pancreas. Who do you have speaking?

  8. Frank van Olffen says

    May 12, 2018 at 10:06 pm

    You forgetting a big player in the Netherlands.

    https://inredadiabetic.nl

    • Chris Newmarker says

      May 16, 2018 at 4:33 pm

      Thanks for pointing out, Frank!

Related Articles Read More >

A photo of Medtronic's Symplicity Spyral renal denervation catheter with a gloved hand for scale.
With Medtronic’s next-gen RDN devices and procedures advancing, Project Galileo is next
MIT emergency drug delivery implantable device glucagon diabetes (1)
Implantable device could save diabetes patients from dangerously low blood sugar
An illustration of the Endogenex ReCET system inside a patient.
This minimally invasive diabetes device delivers pulsed field energy in the gut
UCSD diabetic kidney disease.
New imaging technology offers noninvasive 3D view of diabetic kidney disease
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe